Cowen Downgrades Arena Pharma (ARNA) Ahead of Tomorrow's FDA Panel Meeting

September 15, 2010 7:52 AM EDT Send to a Friend
Traders are continuing to sell shares of the volatile Arena Pharma (Nasdaq: ARNA) this morning, now down another 9% after ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login